Chiome Bioscience Inc. (TYO:4583)

Chiome Bioscience Revenue

Chiome Bioscience had revenue of 126.50M JPY in the quarter ending June 30, 2026, with 11.85% growth. This brings the company's total for the last twelve months to 615.15M, down -19.99% year-over-year. In the year 2025, Chiome Bioscience had annual revenue of 593.29M, down -24.02%. That makes Chiome Bioscience the 40,735th largest company in the world by revenue and 3,826th in Japan.

• Revenue (ttm): 615.15M
• Revenue Growth: -19.99%
• P/S Ratio: 11.80
• Revenue / Employee: 11.61M
• Employees: 53
• Market Cap: 7.26B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Drug Discovery Support Business 577.86M 74.0%
• Drug Discovery Business 202.95M 26.0%

Fiscal year ended Dec 31, 2024 See the full Chiome Bioscience breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	593.29M	-187.52M	-24.02%
Dec 31, 2024	780.81M	98.35M	14.41%
Dec 31, 2023	682.46M	51.65M	8.19%
Dec 31, 2022	630.82M	-82.12M	-11.52%
Dec 31, 2021	712.93M	232.08M	48.26%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 25, 2026

Data Sources Report a data error